NEW YORK — NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing …
KIGALI, Rwanda — Rwandan health authorities will begin a vaccine study against the Marburg hemorrhagic fever, officials said Sunday, as the East African country tries to stop the spread of …
WASHINGTON — A California biotechnology company that helps doctors detect genetic causes for cancer is among those that could be cut out of the U.S. market over ties to China, …
Africa is the world’s fastest-growing region, and the population could double by 2050, putting further strain on healthcare systems. The continent has made progress in controlling infectious diseases but faces …
New Delhi: Paving way for faster launch of breakthrough therapies for conditions like cancer and rare diseases, the Union government Wednesday ordered that certain categories of drugs which have already been …
Promising trials of a new antibiotic drug trademarked as Zaynich – meant to act against all major superbugs – has triggered a sharp run-up in the Wockhardt stock. It has …
A GP of 30 years has hailed the trial of an innovative cancer vaccine as a “significant breakthrough” that will “herald a new age” of cancer treatment, as it is …
Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it ByTOM …
Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost weight but had trouble tolerating the …
More than 40% of American adults are considered obese, yet the medications many take are rarely tested in bigger bodies. That’s because they are not required to be included in …